Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Science

• Publication date

  1986-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.2418504PMID 2418504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

  1985cited by this paper
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

  1985cited by this paper
• Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

  1985cited by this paper
• Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

  1985cited by this paper
• Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.

  1985cited by this paper
• Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

  1985cited by this paper
• Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.

  1985cited by this paper
• Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase.

  1985cited by this paper
• Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

  1984cited by this paper
• Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

  1984cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• Theory and methods for immunization in culture and monoclonal antibody production.

  1982cited by this paper
• Mechanism of action of Moloney murine leukemia virus RNA-directed DNA polymerase associated RNase H (RNase H I).

  1981cited by this paper
• A gas-liquid solid phase peptide and protein sequenator.

  1981cited by this paper
• Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support.

  1980cited by this paper
• Amino Acid Sequence Analysis of Reverse Transcriptase Subunits from Avian Myeloblastosis Virus

  1980cited by this paper
• Endonuclease activity of purified RNA-directed DNA polymerase from avian myeloblastosis virus.

  1979cited by this paper

• A medicinal chemistry overview of direct-acting antivirals approved in 2013-2024 by US FDA.

  2025cites this paper
• HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation

  2023cites this paper
• Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

  2022cites this paper
• Comparison of Reverse Transcriptase (RT) Activities of Various M-MuLV RTs for RT-LAMP Assays

  2022cites this paper
• M-MuLV reverse transcriptase: Selected properties and improved mutants

  2021cites this paper
• In Silico Anti-HIV Analysis of FTIR Identified Bioactive Compounds Present in Vitex altissima L and Vitex leucoxylon L

  2019cites this paper
• Title Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis

  2018cites this paper
• Chaotic dynamics of fractional Vallis system for El-Niño

  2018cites this paper
• Functional assessment on non-neutralizing binding antibodies in the blood and genital tracts of women with breakthrough HIV infection from the CAPRISA 004 1% tenofovir gel trial.

  2017cites this paper
• Probing Conformational States of the Finger and Thumb Subdomains of HIV-1 Reverse Transcriptase Using Double Electron-Electron Resonance Electron Paramagnetic Resonance Spectroscopy.

  2017cites this paper
• Past, Present, and Future Drug Delivery Systems for Antiretrovirals.

  2016influential citation
• Interactions Between HIV-1 TAT and Tumor Suppressor P53

  2016cites this paper
• PUBLISHED VERSION

  2015cites this paper
• When biologist meets chemist: a search for HIV-1 inhibitors

  2015cites this paper
• Lentiviral vectors for gene therapy of Gaucher disease

  2015cites this paper
• Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity

  2015cites this paper
• Non‐Nucleoside HIV Reverse Transcriptase Inhibitors for the Treatment of HIV/AIDS: Design and Development of Etravirine and Rilpivirine

  2015cites this paper
• Design, Synthesis, and Biological Evaluation of Novel 2H‐Pyran‐2‐one Derivatives as Potential HIV‐1 Reverse Transcriptase Inhibitors

  2015cites this paper
• Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components

  2015cites this paper
• Influence of HIV-1 Genetic Variability on Vertical Transmission and Pathogenesis

  2015cites this paper
• Computer-aided design and discovery of protein–protein interaction inhibitors as agents for anti-HIV therapy

  2014cites this paper
• The functional interplay between TNPO3, CPSF6 and HIV-1 CA

  2014cites this paper
• The Nature of the N-Terminal Amino Acid Residue of HIV-1 RNase H Is Critical for the Stability of Reverse Transcriptase in Viral Particles

  2014influential citation
• MODULATION OF HIV-1 REVERSE TRANSCRIPTASE AND FAMILY A DNA POLYMERASE PRIMER-TEMPLATE BINDING

  2014cites this paper
• Host Cell Factors in HIV-1 Replication Cycle

  2014influential citation
• QSAR and docking studies on the diaryltriazine analogs as HIV-1 reverse transcriptase inhibitors

  2014cites this paper
• Structural requirements for enzymatic activities of foamy virus protease‐reverse transcriptase

  2014cites this paper
• Chapter 44 – Human Immunodeficiency Virus 1 Retropepsin

  2013cites this paper
• Gag-Pol Processing during HIV-1 Virion Maturation: A Systems Biology Approach

  2013cites this paper
• Ribonuclease H Inhibitors: Structural and Molecular Biology

  2013cites this paper
• HIV-1-Inhibiting Viral Protein Mutants Type 1 (HIV-1) Variant: Identification of Novel Nonproducer Human Immunodeficiency Virus Homologous Viral Interference Induced by a gag, vif, and nef Genes Contribute to the

  2013cites this paper
• Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis

  2013cites this paper
• Examining the Role of the HIV-1 Reverse Transcriptase p51 Subunit in Positioning and Hydrolysis of RNA/DNA Hybrids*

  2013cites this paper
• Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation

  2013cites this paper
• Binding kinetics and affinities of heterodimeric versus homodimeric HIV-1 reverse transcriptase on DNA-DNA substrates at the single-molecule level.

  2013cites this paper
• Application of fragment screening by x-ray crystallography for the identification of novel chemical scaffolds targeting viral proteins of hiv and influenza

  2013cites this paper
• Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface

  2013cites this paper
• Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance.

  2013cites this paper
• Nucleic Acid Binding Thermodynamics and Functions of DNA Polymerases

  2013cites this paper
• Activity Profiles & Mechanisms of Resistance of 3'-Azido-2',3'-Dideoxynucleoside Analog Reverse Transcriptase Inhibitors of HIV-1

  2013cites this paper
• Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for Use in cDNA Synthesis

  2012cites this paper
• Human Immunodeficiency Virus Reverse Transcriptase: 25 Years of Research, Drug Discovery, and Promise*

  2012cites this paper
• Design, Chemical Synthesis and Biological Evaluation of Potential New Antiviral Agents

  2012cites this paper
• Point Mutations Associated with HIV-1 Drug Resistance, Evasion of the Immune Response and AIDS Pathogenesis

  2012cites this paper
• Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.

  2012cites this paper
• T Cell Responses During Human Immunodeficiency Virus (HIV)-1 Infection

  2012cites this paper
• Dihydro-alkoxyl-benzyl-oxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011).

  2012cites this paper
• Antiretrovirals for HIV Exposure Prophylaxis.

  2012cites this paper
• The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.

  2012cites this paper
• Placement of Leucine Zipper Motifs at the Carboxyl Terminus of HIV-1 Protease Significantly Reduces Virion Production

  2012cites this paper
• Control of Innate and Adaptive Immune Responses during Infectious Diseases

  2012cites this paper
• Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors

  2011cites this paper
• Identification of Alternative Binding Sites for Inhibitors of HIV-1 Ribonuclease H Through Comparative Analysis of Virtual Enrichment Studies

  2011cites this paper
• Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.

  2011cites this paper
• Retrotransposon-Encoded Reverse Transcriptase in the Genesis, Progression and Cellular Plasticity of Human Cancer

  2011cites this paper
• Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase

  2011cites this paper
• Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors.

  2011cites this paper
• Diferenciação entre soroconversão recente e de longo termo na infecção pelo HIV-1 implicações nos estudos sobre dinâmica da epidemia, diversidade viral, vigilância da resistência aos antirretrovirais e patogênese

  2011cites this paper
• Modelling the binding of HIV-reverse transcriptase and nevirapine: an assessment of quantum mechanical and force field approaches and predictions of the effect of mutations on binding.

  2010cites this paper
• Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.

  2010cites this paper
• Efavirenz binding site in HIV-1 reverse transcriptase monomers.

  2010cites this paper
• The Role of the Protease Cleavage Sites in Viral Fitness and Drug Resistance in HIV-1 Subtype C

  2010cites this paper
• Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.

  2010influential citation
• Purification of untagged HIV-1 reverse transcriptase by affinity chromatography.

  2010cites this paper
• The “Connection” Between HIV Drug Resistance and RNase H

  2010cites this paper
• A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility*

  2009cites this paper
• A Single Amino Acid Substitution in HIV-1 Reverse Transcriptase Significantly Reduces Virion Release

  2009cites this paper
• Molecular Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors

  2009cites this paper
• Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors.

  2009cites this paper
• HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies

  2009cites this paper
• Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV.

  2009cites this paper
• Binding of the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz to HIV-1 Reverse Transcriptase Monomers and Dimers

  2009influential citation
• HIV ribonuclease H: continuing the search for small molecule antagonists.

  2009cites this paper
• A polymerase-site-jumping model for strand transfer during DNA synthesis by reverse transcriptase.

  2009cites this paper
• Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production.

  2009cites this paper
• Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors

  2009cites this paper
• Factors That Promote Recombination during HIV-1 Reverse Transcription and Properties of M184 Drug Resistant Reverse Transcriptases

  2009cites this paper
• Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.

  2009cites this paper
• Human Immunodeficiency Virus Reverse Transcriptase

  2009cites this paper
• Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits.

  2009influential citation
• A Single Amino Acid Substitution in HIV-1 Reverse Transcriptase Significantly Reduces Virion Release (cid:1)

  2009cites this paper
• A Reverse Transcriptase-Dependent Mechanism Plays Central Roles in Fundamental Biological Processes

  2008cites this paper
• RNase H activity: structure, specificity, and function in reverse transcription.

  2008cites this paper
• HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells

  2008cites this paper
• Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants.

  2008cites this paper
• Human Immunodeficiency Virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells

  2008cites this paper
• AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription.

  2008cites this paper
• Strand transfer events during HIV-1 reverse transcription.

  2008cites this paper
• HIV-1 reverse transcription initiation: a potential target for novel antivirals?

  2008cites this paper
• HIV-1 Transmission, Replication Fitness and Disease Progression

  2008cites this paper
• STUDIES OF THE DIMERIZATION AND PACKAGING SIGNALS IN HIV-2 RNA

  2008cites this paper
• Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines.

  2008cites this paper
• Nucleocapsid protein modulates the specificity of plus strand priming and recombination patterns in Human Immunodeficiency Virus

  2008cites this paper
• Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo.

  2007influential citation
• Coupling selection of the HIV-1 tRNA primer used for reverse transcription with viral translation and encapsidation

  2007cites this paper
• Coat protein of cauliflower mosaic virus binds to ssDNA

  2007cites this paper
• Exploiting structurally diverse nucleoside analogs as probes of reverse transcription complexes.

  2007cites this paper
• Analysis of the contact interfaces of HIV reverse transcriptase subunits

  2007cites this paper
• Reverse transcriptase activity in human normal and psoriatic skin samples

  2007cites this paper
• In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity.

  2007cites this paper